Thus, due to the capability of detecting both 3R and 4R tauopathies, the tau PET [18F]Florzolotau may play a role in the differential diagnosis of other neurodegenerative cognitive disorders such as FTD and DLB. This evidence concerns the gene MAPT and Lewy body dementia.